Convergence Pharmaceuticals clinical trials
Acquired by Biogen, Feb 12, 2015 · source ↗
The registry lists 2 studies whose lead sponsor is Convergence Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2014.
Before and after it joined Biogen
- First submitted before Convergence Pharmaceuticals became part of Biogen
- 2
- First submitted after Convergence Pharmaceuticals became part of Biogen
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Convergence Pharmaceuticals2 studies
Something wrong with this grouping? Tell us on the Biogen page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Biogen studies →
- Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic NeuralgiaCompletedNCT01848730Phase 2
Sponsor listed in the registry: Convergence Pharmaceuticals · First submitted before Convergence Pharmaceuticals became part of Biogen
- Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral NeuropathyCompletedNCT01893125Phase 2
Sponsor listed in the registry: Convergence Pharmaceuticals · First submitted before Convergence Pharmaceuticals became part of Biogen